Get Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Insider Selling: athenahealth, Inc. (NASDAQ:ATHN) SVP Sells 300 Shares of Stock

athenahealth, Inc. (NASDAQ:ATHN) SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction on Monday, July 17th. The stock was sold at an average price of $143.13, for a total transaction of $42,939.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Get Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Jonathan D. Porter also recently made the following trade(s):

athenahealth, Inc. (NASDAQ ATHN) traded up 9.64% during mid-day trading on Friday, hitting $157.66. 773,394 shares of the stock were exchanged. The stock’s 50 day moving average is $141.51 and its 200 day moving average is $122.62. athenahealth, Inc. has a 52-week low of $90.11 and a 52-week high of $158.66. The stock has a market cap of $6.28 billion, a PE ratio of 310.35 and a beta of 1.79.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The company’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.34 earnings per share. Analysts forecast that athenahealth, Inc. will post $1.86 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “[[title]]” was first posted by [[site]] and is the sole property of of [[site]]. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at [[permalink]].

Several large investors have recently modified their holdings of ATHN. Norges Bank acquired a new stake in shares of athenahealth during the fourth quarter worth $20,750,000. Rockefeller Financial Services Inc. increased its stake in athenahealth by 13.1% in the first quarter. Rockefeller Financial Services Inc. now owns 8,445 shares of the health services provider’s stock valued at $952,000 after buying an additional 975 shares during the period. Teachers Advisors LLC increased its stake in athenahealth by 3.0% in the fourth quarter. Teachers Advisors LLC now owns 74,094 shares of the health services provider’s stock valued at $7,792,000 after buying an additional 2,190 shares during the period. Allen Investment Management LLC purchased a new stake in athenahealth during the first quarter valued at $415,000. Finally, Highbridge Capital Management LLC purchased a new stake in athenahealth during the fourth quarter valued at $13,599,000.

Several research analysts have recently weighed in on ATHN shares. Jefferies Group LLC reiterated a “sell” rating and set a $95.00 price target on shares of athenahealth in a research note on Friday, March 24th. BidaskClub upgraded shares of athenahealth from a “hold” rating to a “buy” rating in a research report on Saturday, June 24th. Citigroup Inc. set a $128.00 price objective on shares of athenahealth and gave the company a “buy” rating in a research report on Monday, May 1st. Cantor Fitzgerald restated a “buy” rating and set a $118.00 price objective (down from $135.00) on shares of athenahealth in a research report on Thursday, April 27th. Finally, Piper Jaffray Companies restated an “overweight” rating and set a $160.00 price objective on shares of athenahealth in a research report on Tuesday, April 4th. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $141.00.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.